HDL proteome in hemodialysis patients: a quantitative nanoflow liquid chromatography-tandem mass spectrometry approach.

HDL proteome in hemodialysis patients: a quantitative nanoflow liquid chromatography-tandem mass spectrometry approach.

Aside from a decrease in the high-density lipoprotein (HDL) cholesterol levels, qualitative abnormalities of HDL can contribute to an increase in cardiovascular (CV) risk in end-stage renal disease (ESRD) patients undergoing chronic hemodialysis (HD). Dysfunctional HDL leads to an alteration of reve...

Full description

Bibliographic Details
Main Authors: Alain Mangé, Aurélie Goux, Stéphanie Badiou, Laure Patrier, Bernard Canaud, Thierry Maudelonde, Jean-Paul Cristol, Jérôme Solassol
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3309955?pdf=render

Internet

http://europepmc.org/articles/PMC3309955?pdf=render

Similar Items